Latest PTEN Stories
ASCO Abstract #10504. Contrary to what many oncologists had thought, a tumor suppressor protein known as PTEN does not reduce the effectiveness of the breast cancer drug Herceptin.
Mayo Clinic researchers have found a mutant gene, which was long thought to accelerate tumor growth in thyroid cancer patients, actually inhibits the spread of cancerous cells.
Prostate cancer affects many men nationwide, and if caught early enough is curable, but little is understood about the mechanisms that cause a tumor to metastasize and spread to other parts of the body.
A protein known as WWP2 appears to play a key role in tumor survival, a research team headed by a scientist at The University of Texas MD Anderson Cancer Center reports in an advance online publication of Nature Cell Biology.
Mutations in three pathways important for suppressing tumors cooperate to launch glioblastoma, an aggressive brain tumor that strikes children and adults.
Breast cancer tumors take numerous paths to resist the targeted drug Herceptin, but a single roadblock at a crucial crossroads may restore a tumor's vulnerability to treatment.
Cerebrospinal fluid (CSF), the fluid found in and around the brain and spinal cord, may play a larger role in the developing brain than previously thought.
JAMAICA PLAIN, Mass., March 1, 2011 /PRNewswire/ -- Paloma Pharmaceuticals, Inc. announced today updates on its age-related macular degeneration Phase I trials and oncology program.
Prostate tumors that carry a "signature" of four molecular markers have the potential to become dangerously metastatic if not treated aggressively.
Researchers have discovered a method for more precise identification of individuals who should undergo testing for genetic mutations of the tumor suppressor gene PTEN, which associates with a variety of conditions including several types of cancers.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.